Editorial: crystal gazing with magnetic resonance enterography to predict the response to TNF-alpha inhibitors in Crohn's disease

Aliment Pharmacol Ther. 2020 Nov;52(9):1531-1532. doi: 10.1111/apt.16104.

Authors

Maria Zulfiqar¹, Parakkal Deepak²

Affiliations

¹ Department of Radiology, Mallinckrodt Institute of Radiology, Washington University in Saint Louis, St. Louis, MO, USA.
² Division of Gastroenterology and Inflammatory Bowel Diseases Center, Washington University in Saint Louis, St. Louis, MO, USA.

PMID: 33263379
DOI: 10.1111/apt.16104

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Crohn Disease* / diagnostic imaging
Crohn Disease* / drug therapy
Humans
Magnetic Resonance Imaging
Magnetic Resonance Spectroscopy
Tumor Necrosis Factor Inhibitors
Tumor Necrosis Factor-alpha*

Substances

Tumor Necrosis Factor Inhibitors
Tumor Necrosis Factor-alpha